Novel genetic analyzer advances capabilities of Sanger sequencing

By The Science Advisory Board staff writers

February 9, 2022 -- Capillary electrophoresis (CE), which enables Sanger sequencing and fragment analysis, is an important tool for improving clinical research and advancing scientific discovery. To further enable customers' cutting-edge research in areas such as gene editing and infectious disease, Thermo Fisher Scientific has introduced the new Applied Biosystems SeqStudio Flex Series Genetic Analyzer.

The Applied Biosystems SeqStudio Flex Series Genetic Analyzer.
The Applied Biosystems SeqStudio Flex Series Genetic Analyzer. Image courtesy of Thermo Fisher.

The Flex Series analyzer delivers high-quality Sanger sequencing and fragment analysis data. Building on Applied Biosystems technology, the new midthroughput genetic analyzer introduces design and technological advancements for enhanced flexibility, usability, and connectivity. The instrument has increased plate capacity and may be loaded at any time without canceling or waiting for a run to complete, improving sample throughput, walk-away capacity, and scheduling flexibility, Thermo Fisher said.

In addition, the system's advanced Wi-Fi connectivity enables users to remotely set up and monitor runs, as well as to facilitate streamlined data transfer, analysis, and scientific collaboration. The SeqStudio Flex Series Genetic Analyzer is also the first CE-based instrument with remote servicing capabilities for faster issue resolution.


Copyright © 2022 scienceboard.net
 

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:



Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Email Preferences



Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.